Factors That Predict Response of Patients With Hepatitis B e Antigen–Positive Chronic Hepatitis B to Peginterferon-Alfa
Top Cited Papers
Open Access
- 1 December 2009
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 137 (6), 2002-2009
- https://doi.org/10.1053/j.gastro.2009.08.061
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2bGastroenterology, 2008
- Chronic hepatitis BHepatology, 2007
- A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis BThe New England Journal of Medicine, 2006
- Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trialThe Lancet, 2005
- Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver DiseaseThe New England Journal of Medicine, 2004
- Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis BHepatology, 2004
- Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measuresJournal of Viral Hepatitis, 2004
- Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infectionHepatology, 1999
- Long-term follow-up of patients with chronic hepatitis B treated with interferon alfaGastroenterology, 1997
- Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infectionGastroenterology, 1987